Page last updated: 2024-08-23

sufentanil and androstane-3,17-diol

sufentanil has been researched along with androstane-3,17-diol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Estafanous, FG; Koehler, LS; Kraenzler, EJ; Starr, NJ; Wong, D	1

Trials

1 trial(s) available for sufentanil and androstane-3,17-diol

Article	Year
Comparison of cardiovascular effects of pipecuronium versus vecuronium in patients receiving sufentanil anesthesia for myocardial revascularization. Journal of cardiothoracic and vascular anesthesia, 1991, Volume: 5, Issue:2 Topics: Androstane-3,17-diol; Anesthesia, Intravenous; Anesthetics; Blood Pressure; Cardiac Output; Central Venous Pressure; Coronary Artery Bypass; Female; Fentanyl; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Muscle Relaxants, Central; Neuromuscular Nondepolarizing Agents; Pipecuronium; Piperazines; Pulmonary Wedge Pressure; Sufentanil; Vascular Resistance; Vecuronium Bromide	1991

Article

Year

Comparison of cardiovascular effects of pipecuronium versus vecuronium in patients receiving sufentanil anesthesia for myocardial revascularization.

Journal of cardiothoracic and vascular anesthesia, 1991, Volume: 5, Issue:2

Topics: Androstane-3,17-diol; Anesthesia, Intravenous; Anesthetics; Blood Pressure; Cardiac Output; Central Venous Pressure; Coronary Artery Bypass; Female; Fentanyl; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Muscle Relaxants, Central; Neuromuscular Nondepolarizing Agents; Pipecuronium; Piperazines; Pulmonary Wedge Pressure; Sufentanil; Vascular Resistance; Vecuronium Bromide

1991